首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Validation of the Doser, a new device for monitoring metered-dose inhaler use.
【24h】

Validation of the Doser, a new device for monitoring metered-dose inhaler use.

机译:验证Doser,这是一种用于监视定量吸入器使用情况的新设备。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Electronic monitoring of medication use has proved valuable in both clinical and research settings. The Doser, a new and inexpensive commercially available device for monitoring metered-dose inhaler (MDI) use, displays 3 measures of daily use of an attached MDI: (1) the daily total of actuations, (2) the number of doses remaining in the MDI, and (3) the number of actuations on each of the preceding 30 days for later recall. OBJECTIVE: We sought to validate the accuracy of the Doser with several commonly prescribed MDIs. METHODS: In the laboratory, clinic personnel actuated an MDI with an attached Doser several times in succession on 3 consecutive days and recorded each of the 3 measures of MDI use (study 1). In study 2 clinic personnel carried an MDI and attached Doser with them for 4 weeks, actuating the MDI according to a prescribed protocol each morning and evening and again recording each of the 3 measures of daily use. In addition, during 2 weeks of study 2, a thermistor-based Nebulizer Chronolog was attached to the MDI to electronically record the date and time of each actuation. In study 3 clinic patients had both a Doser and Nebulizer Chronolog attached to their routinely used inhalers for 2 weeks and a Doser alone during a separate 2-week period. RESULTS: In study 1 agreement was 99% to 100% among the 3 Doser measures, and each measure agreed with actual use by self-report 97% of the time. In study 2 agreement among the 3 Doser measures of use ranged from 98% to 99%. Agreement between each of the 3 Doser measures and the Nebulizer Chronolog ranged from 90% to 93%. Agreement between each of the 3 Doser measures and actual use ranged from 96% to 97%, and the Nebulizer Chronolog agreed with actual use 93% of the time. In study 3 Doser and Nebulizer Chronolog agreement with patient self-report were 85% and 80%, respectively. Agreement between the Doser and Nebulizer Chronolog was 76%. Several failures of the thermistor-based Nebulizer Chronolog occurred, and occasional mechanical problems occurred with the Doser, primarily on particular types of MDI canisters. CONCLUSION: The Doser provides an accurate measure of MDI use with most commonly prescribed medications and may be useful for monitoring MDI use by investigators, clinicians, and patients.
机译:背景:药物使用的电子监控已被证明在临床和研究环境中都很有价值。 Doser是一种用于监视计量吸入器(MDI)使用情况的新型,廉价的市售设备,它显示了所连接的MDI每日使用情况的3种度量:(1)每天的总致动量;(2)剩余的剂量数MDI,以及(3)前30天中的每一天的促动次数,以供以后调用。目的:我们试图通过几种常用的MDI来验证Doser的准确性。方法:在实验室中,诊所工作人员连续3天连续数次用连接的Doser启动MDI,并记录了3种MDI使用量中的每一种(研究1)。在研究中,2名临床人员携带MDI并与Doser一起使用了4周,每天早晨和傍晚根据规定的方案启动MDI,并再次记录每天使用的3种措施。此外,在研究2的2周内,将基于热敏电阻的雾化器Chronolog连接到MDI,以电子方式记录每次启动的日期和时间。在研究中,有3名临床患者在常规吸入器上同时安装了Doser和雾化器Chronolog,为期2周,而在单独的2周内仅使用Doser。结果:在研究中,在3项Doser措施中,有1项协议的使用率为99%至100%,并且每种措施与97%的自我报告的实际使用情况相符。在研究中,使用3种Doser措施中的2种一致性从98%到99%不等。这三种剂量方法与雾化器时序记录之间的一致性介于90%至93%之间。这三种剂量方法与实际使用之间的一致性从96%到97%不等,而雾化器Chronolog在93%的时间内同意实际使用。在研究3中,患者自我报告的Doser和Nebulizer Chronolog一致性分别为85%和80%。 Doser和雾化器Chronolog之间的协议率为76%。基于热敏电阻的雾化器Chronolog发生了几次故障,并且Doser偶尔发生机械故障,主要是在特定类型的MDI罐上。结论:本剂量提供了最常用处方药物对MDI使用的准确测量,对于监测研究者,临床医生和患者对MDI的使用可能很有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号